Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist

Natasha T. Snider, James A. Nast, Laura A. Tesmer and Paul F. Hollenberg
Molecular Pharmacology April 2009, 75 (4) 965-972; DOI: https://doi.org/10.1124/mol.108.053439
Natasha T. Snider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Nast
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura A. Tesmer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul F. Hollenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 75 no. 4 965-972
DOI 
https://doi.org/10.1124/mol.108.053439
PubMed 
19171674

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received November 13, 2008
  • Accepted January 26, 2009
  • Published online March 18, 2009.

Article Versions

  • Earlier version (January 26, 2009 - 06:38).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Natasha T. Snider,
  2. James A. Nast,
  3. Laura A. Tesmer and
  4. Paul F. Hollenberg
  1. Department of Pharmacology (N.T.S., J.A.N., P.F.H.) and Division of Rheumatology, Department of Internal Medicine (L.A.T.), University of Michigan Medical School, Ann Arbor, Michigan
  1. Address correspondence to:
    Dr. Paul F. Hollenberg, Department of Pharmacology, The University of Michigan, 2301 MSRB III, 1150 West Medical Center Dr., Ann Arbor, Michigan 48109-5632. E-mail: phollen{at}umich.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2009 to March 2023

AbstractFullPdf
Jan 200931069
Feb 2009170135
Mar 20099618111
Apr 2009625457
May 2009262818
Jun 2009202017
Jul 2009241021
Aug 2009141714
Sep 2009291819
Oct 200940620
Nov 2009281620
Dec 200918913
Jan 20104188
Feb 20102588
Mar 2010361310
Apr 2010351514
May 2010351110
Jun 2010591112
Jul 2010311115
Aug 201027615
Sep 2010441017
Oct 2010351913
Nov 2010202316
Dec 2010171713
Jan 201115811
Feb 2011221613
Mar 2011291611
Apr 2011131310
May 2011131414
Jun 201112116
Jul 2011131013
Aug 2011221612
Sep 2011112912
Oct 201111216
Nov 2011141810
Dec 2011182217
Jan 20122057
Feb 2012161511
Mar 2012201313
Apr 2012122213
May 2012193815
Jun 201218179
Jul 2012171416
Aug 201218811
Sep 2012141011
Oct 2012121220
Nov 20121457
Dec 2012171611
Jan 201321117
Feb 201319179
Mar 20131463
Apr 20131578
May 20138119
Jun 20131366
Jul 2013965
Aug 2013412
Sep 20131173
Oct 20137118
Nov 2013498
Dec 20131333
Jan 20141578
Feb 2014281714
Mar 20144276
Apr 2014632
May 201413106
Jun 2014954
Jul 2014464
Aug 20141252
Sep 20141811
Oct 20141694
Nov 20141575
Dec 20141133
Jan 20151875
Feb 2015885
Mar 20151287
Apr 20151095
May 20151599
Jun 2015980
Jul 201513127
Aug 201513135
Sep 20156147
Oct 2015372
Nov 2015674
Dec 2015786
Jan 201620610
Feb 201623911
Mar 20161179
Apr 20162036
May 20166311
Jun 20163520
Jul 20167109
Aug 2016394
Sep 20169119
Oct 20162133
Nov 201610168
Dec 201633813
Jan 20170245
Feb 20170143
Mar 20172206
Apr 20170142
May 20170313
Jun 201702211
Jul 20171119
Aug 2017289
Sep 2017086
Oct 20170144
Nov 20171257
Dec 2017094
Jan 2018085
Feb 20180196
Mar 20180248
Apr 20180248
May 201801313
Jun 20180107
Jul 2018093
Aug 2018072
Sep 20180110
Oct 20180112
Nov 20180167
Dec 2018933
Jan 2019700
Feb 20191306
Mar 20191816
Apr 20191027
May 20191204
Jun 2019216
Jul 2019704
Aug 20191543
Sep 20191842
Oct 2019910
Nov 20192123
Dec 20193712
Jan 20202831
Feb 20202664
Mar 20201553
Apr 20201153
May 2020711
Jun 20201600
Jul 20201501
Aug 2020411
Sep 2020921
Oct 202024101
Nov 20202331
Dec 20201122
Jan 2021833
Feb 2021875
Mar 20211652
Apr 20211353
May 20212142
Jun 20211040
Jul 20211031
Aug 20211741
Sep 2021431
Oct 2021833
Nov 20211164
Dec 20212112
Jan 20221411
Feb 20221351
Mar 2022312
Apr 20222233
May 20221222
Jun 20221311
Jul 2022923
Aug 2022921
Sep 2022721
Oct 20221231
Nov 2022832
Dec 20221510
Jan 20232944
Feb 2023712
Mar 20232511

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 75 (4)
Molecular Pharmacology
Vol. 75, Issue 4
1 Apr 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist

Natasha T. Snider, James A. Nast, Laura A. Tesmer and Paul F. Hollenberg
Molecular Pharmacology April 1, 2009, 75 (4) 965-972; DOI: https://doi.org/10.1124/mol.108.053439

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist

Natasha T. Snider, James A. Nast, Laura A. Tesmer and Paul F. Hollenberg
Molecular Pharmacology April 1, 2009, 75 (4) 965-972; DOI: https://doi.org/10.1124/mol.108.053439
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics